Concepedia

Publication | Closed Access

BYL719, a next generation PI3K alpha specific inhibitor: Preliminary safety, PK, and efficacy results from the first-in-human study

39

Citations

0

References

2012

Year

Dejan Juric, Jordi Rodón, AM Gonzalez-Angulo, Howard A. Burris, J.C. Bendell, J. Berlin, Mark R. Middleton, Douglas Bootle, Markus Boehm, Antonin Schmitt,
Cancer Research

No additional data available for this publication yet. Check back later!